Latest Breaking News On - Drug advisory committee - Page 1 : comparemela.com

Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript

Dr Kirkwood on the Evolving Treatment of Resected Melanoma

John M. Kirkwood, MD, discusses the significance of the FDA approval of adjuvant nivolumab for patients with resected stage IIB or IIC melanoma.

Targeted Pulse: Social Determinants Link to Cervical Cancer, FDA News, and More

This week's Targeted Pulse focuses on the latest in cervical cancer, the FDA ODAC's vote for cilta-cel, and more.

FDA removal of decongestants made with ineffective drug would disrupt drug supply chain, experts say

In the event of administrative removal of these products, clinicians and consumers could substitute oral pseudoephedrine or intranasal decongestants such as phenylephrine or oxymetazoline, the authors say.